chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24 hrs after dose Rotavirus developed severe abdominal pain, inconsolable, bloody stool to medical center ER -> after testing-intussusception which then reduced itself. Pt doing well now-Hx per mother.  7/6/07 Received complete vax records which confirms RO lot & dose # as reported by corrected some other vax lot #s.  VAERS database updated w/same.  8/28/07 Received hospital medical records from CDC which reveal patient experienced excessive crying & seen in ER on 6/13/07.  DX: irritable infant.  Returned to ER on 6/14 w/continued crying & screaming episodes & bloody stool.  Abdomen soft & mildly tender on palpation w/+ BS.  DX: fussy infant.
So I received the two covid shots first on 03/23/2021 and second on 04/28/2021. I had mild psoriasis on my hand and a discoloration patch the size of 2" diameter was present on the inside of my elbow. The psoriasis inside of my elbow started spreading starting April slowly and it happened on both my hands, and as of today 75% of my hands are covered with a sudden inflation of psoriasis. This was accompanied by burning and irresistible itching of the flared-up skin. I have done nothing different was leading normal life, eating healthy and working out regularly for this condition to have developed suddenly. I truly feel this is a result off the covid vaccine though I don't think I can ever prove it.
MOC STATES RASH APPEARED ON BODY 3 DAYS AFTER RECEIVING VACCINES.  MOC STATES BABY BECAME RIGID, EYES ROLLED BACK, CHILD TURNED RED AND GASP FOR AIR.  MOC BLEW INTO CHILD'S FACE AND CHILD RESUMED BREATHING.  CHILD WAS IMMEDIATELY TAKEN TO THE ER.
INJECTION SITE BECAME SWOLLEN HOT RED AND ITCHY. PT HAS BEEN EXPERIENCING ITCHY RASH EVER SINCE. SHE TOOK ONE DOSE FROM A MEDROL DOSPAK WHICH DID NOT HELP, I ADVISED HER TO GET AND TAKE SOME DIPHENHYDRAMINE AND TO SEE HER MD OR OTHER DOCTOR CARE AS SOON AS POSSIBLE.
Lower Back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower Back pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported).    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced BACK PAIN (Lower Back pain). At the time of the report, BACK PAIN (Lower Back pain) outcome was unknown. Not Provided          Treatment received in response to the event was not reported.
40 year old female patient reports having had a reaction minutes after her first dose of the COVID-19 PFIZER Biotechnic vaccine. Signs after the vaccination: Patient refers that at the moment of observation, once the vaccinated, she began with chest pain, dizziness was observed for 30 minutes. The patient refers that it was at the moment and that there was no consecutive duration between chest pain and dizziness. Patient suffers from panic attacks, argues that after vaccinations she had to undergo surgery actions for 7 stones in the kidneys which she did not know at the time. Patient presented nodules in the neck area for a week on the of the same vaccination day. Doctor authorized the patient to obtain 2nd dose after passing the entire operation process.
HEART PROBLEMS; ALMOST DIED; This spontaneous report received from a consumer via a company representative via social media concerned multiple patients (2 patients) of unspecified age, sex, race and ethnicity. The patient's height and weight were not reported. The patient's pre-existing medical conditions included: The patients had no health conditions or problems at all before the vaccine and never had covid. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy dates were not reported, 1 total, administered for covid-19 prophylaxis. The batch number was not reported. Per procedure no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patients wound up in the hospital and one of them almost died (adverse event not specified) and they both had heart problems and were under the care of a heart specialist (had physician office visit). The number of days of hospitalization was not reported. As per reporter, "One small example was two people in our family never had covid but went and got the covid shots and wound up in the hospital and one of them almost died now they both have heart problems and are under the care of a heart specialist now probably for the rest of their lives neither one of them had any health conditions or problems at all before the vaccine". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the heart problems and almost died was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0 : 20221251578-Heart problem. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.  20221251578- Almost died. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.
hollow electric pain in my back that would shoot down my legs whenever I bent it even a little; my feet are feeling numb with occasional pins; my feet are feeling numb with occasional pins; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on 28Jan2021 12:15 as single dose for covid-19 immunisation. Medical history included generalized anxiety and major depressive disorder, but no other chronic conditions. No known allergies. Patient was not tested for Covid prior vaccination. Concomitant medications included bupropion hydrochloride (BUPROPION HCL XL, brand Zyrtec) at 450mg and cetirizine hydrochloride (ZYRTEC), both received in two weeks. No other vaccine received in four weeks. On 29Jan2021 at 08:00 AM, the day after she experienced what she would describe as hollow electric pain in her back that would shoot down her legs whenever she bent it even a little. On 30Jan2021 (Today) her feet were feeling numb with occasional pins and needles sensations. No treatment was received for events. Patient was not tested for Covid tested post vaccination. The outcome of events not recovered.  Follow-up attempts completed. No further information expected.
Headache; Body aches; Tiredness; Sore entire arm- still sore; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENO158) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of COVID-19 vaccine. On 16Apr2021 at 14:30, the patient experienced headache, body aches, tiredness, sore entire arm- still sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, body aches, tiredness was recovered with sequelae at the time of this report. While the clinical outcome of the event sore entire arm was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Vaccine was given 7 days past beyond use date. Per Pfizer Manager of Quality Operations, Staff stated, their data stated, "Stability assessment indicates there is no product quality impact and the vaccine was suitable for use."
Headache, fever, body ache.  Acetaminophen and ibuprofen used to treat. Fever, headache and body ache subsided after nine hours.
pulmonary embolus; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0170) via an unspecified route of administration at left arm on 06May2021 (42-year-old at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history included COVID-19 (prior vaccination), asthma, allergies to sulfa, and allergies to PCN. Concomitant medications in two weeks included escitalopram oxalate (LEXAPRO), fexofenadine hydrochloride (ALLEGRA), and multivitamin (unspecified). The patient previously received naproxen sodium (NAPROXEN SOD) and experienced allergies; ipratropium bromide (ATROVENT) and experienced allergies. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9810) via an unspecified route of administration at right arm on 15Apr2021 (42-year-old at time of vaccination), at single dose, for COVID-19 immunization. There was no other vaccine in four weeks. The patient experienced pulmonary embolus on 07May2021. Adverse event resulted in emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). The patient did not test for COVID-19 post vaccination. Therapeutic measures were taken as a result of the event and included blood thinner. The outcome of the event was recovering.
Sore arm and minor headache by about 6 hours; severe shaking/chills and no sleep by about 14 hours...lasting 3 hours
Patient was given the Pfizer monovalient covid vaccine as a booster instead of the bivalent. The monovalient vial was pulled from the bivalent multidose box, that was stored in the fridge, and the nurses administering thought it was the bivalient.
Pt reported dizziness and was observed coughing and continuing to c/o of SOB.  Pt reported chest tightness and throat tightness.
Pt given Engerix-B experienced dizziness, non responder, feeling of faintness, flank pain rt side, nausea became very pale, decreased potassium, and back pain rt side. Was admitted to hospital given Phenergan 25 mg & Demerol to relieve pain
i was like having covid all over again; i was like having covid all over again; has had stomach issues ever since then and is dealing with that and its been a year; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 75 year-old female patient received bnt162b2 (BNT162B2), administration date 24Jan2021 (Lot number: EL1283) at the age of 75 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "i was like having covid all over again"; GASTRIC DISORDER (non-serious), outcome "unknown", described as "has had stomach issues ever since then and was dealing with that and its been a year". Patient history and investigation assessment was not provided. Clinical course The reporter had her first dose on 24Jan2021 but it was too close to after she had covid, so she had a bad reaction. At the time, the allergist said don't take the second shot and same with her Primary care provider. It was now one year later and the patient was wondering if she could have her second shot now because on her vaccination card it will not allow her to travel. The only thing that the patient wanted to add to her safety report was that she  had stomach issues ever since then and was dealing with that and its been a year. the patient stated "i was like having covid all over again i had the shot apparently too close to when i had covid and i am now one year later trying to have the second dose of the shot i'm hoping i won't have a reaction".  No follow-up attempts are possible. No further information is expected.
Noticed face swelling; This is a spontaneous report from a contactable Consumer.  A 53-years-old male patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EL9267), dose 1 via an unspecified route of administration, administered in Arm Left on 09Feb2021 14:30 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included seasonal allergy, covid-19. Other medical history none. Concomitant medication(s) included enalapril (ENALAPRIL); atorvastatin (ATORVASTATIN); hydrochlorothiazide (HYDROCHLOROTHIAZIDE). On 10Feb2021 21:00 patient noticed face swelling. No treatment for event. The outcome of event was not recovered.  Follow-up (17May2021): Follow-up attempts completed. No further information expected.
I woke up in the early hours of 10/13/23 with a headache and pressure in my sinuses and a sore throat. Body aches. Headaches got worse and so did the sinus pressure. Ringing in the ears. Severe fatigue. Excessive and nasty drainage. A horrible cough. I went through 6 large paper towel rolls to clean up the amount of drainage I was producing. My right eye swelled shut. Minor eye pain when I look left or right. Doing a little better today.
DAY AFTER VACCINATION, DEVELOPED LOW GRADE FEVER AND BODY ACHES.
2 days post vax, the pt experienced tremendous swelling of injection site with redness, hot to the touch and somewhat painful. Swollen from the hip to the knee. Erythema covered a 25cm x 25cm area.
Swollen lymph node developed in my right underarm within 48 hours of receiving my 2nd vaccine & lasted for approximately 7 days. Swollen lymph node reoccurred & was 1st detected on September 12,2021 in the same location. The swelling has still not gone away.
Presented with SOB; Covid + in ED; Admitted to medical facility with Covid PNA, tx with steroids, merrem, remdesivir, pulmicort, Vit C, Baricitinib, symbicort, zinc; supplemental O2 required..up to 12 LPM; back to 4LPM baseline at d/c The facility that she came from will not be able to take her for 10 days after the initial COVID test.  She is able to go to another facility for now until she is able to go back to her skilled nursing facility.
Blisters on hands; Achy joints; This spontaneous case was reported by a physician and describes the occurrence of BLISTER (Blisters on hands) and ARTHRALGIA (Achy joints) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ADALIMUMAB (HUMIRA) for Ankylosing spondylitis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLISTER (Blisters on hands) and ARTHRALGIA (Achy joints). At the time of the report, BLISTER (Blisters on hands) and ARTHRALGIA (Achy joints) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
PATIENT CAME BACK TO THE OFFICE WITH A 5 X 6cm AREA OF REDNESS AND TENDERNESS RT LATERAL ARM
Itchy rash surrounding injection site.  Started one day later, started to improve 6 days later, still present 7 days later
Information has been received from a certificated medical assistant concerning a 12 month old patient who on 08-APR-2010 was intended to receive the first dose of VARIVAX (Merck), was inadvertently administered a dose of ZOSTAVAX (Merck). No adverse effects were reported. Follow up information received from a certificated medical assistant concerning a 13 month old female who on 08-APR-2010 at 11:32 a.m. was vaccinated with a first dose of ZOSTAVAX (Merck) (reported lot # as "664628/1018Y" which is valid for VARIVAX (Merck) in the right thigh. On 11-APR-2010 at 12:00 pm, 3 days after receiving ZOSTAVAX (Merck), the patient experienced vomiting and fever lasted a week. Rash showed up 10 days after receiving the vaccine and lasted for 5 days. They followed up with the patient and no treatment was given. The patient was recovered on 24-APR-2010. No further information is available.
Losing your voice; Getting a cough; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (Losing your voice) and COUGH (Getting a cough) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced APHONIA (Losing your voice) and COUGH (Getting a cough). At the time of the report, APHONIA (Losing your voice) and COUGH (Getting a cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Treatment medication was not provided.
1.  My menstruation occurred twice in a month which has never happened to me before.  I am very regular at 28 day cycle.  It also came in clumps of blood, like blood clots.  2.  I feel random palpitations when I am sitting and relaxing, almost as if my heart skips a beat.  I do have a heart murmur.  But I?ve never felt this unless I was very nervous about a stressful event. However now it happens when I am relaxed.   This all started maybe 2 weeks after second dose of the vaccine.
Extreme muscle pain and weakness throughout entire body. Extreme joint pain throughout entire body. I'm barely about to walk up/down steps, sit on toilet, or dress.; Extreme muscle pain and weakness throughout entire body. Extreme joint pain throughout entire body. I'm barely about to walk up/down steps, sit on toilet, or dress.; Extreme muscle pain and weakness throughout entire body. Extreme joint pain throughout entire body. I'm barely about to walk up/down steps, sit on toilet, or dress.; Extreme muscle pain and weakness throughout entire body. Extreme joint pain throughout entire body. I'm barely about to walk up/down steps, sit on toilet, or dress.; This is a spontaneous report from a contactable consumer (patient). A 42-years-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0183, (Aug2021, as reported)), dose 2 via an unspecified route of administration, administered in Arm Left on 05Aug2021 at 13:00 (at the age of 42-years-old) as dose 2, single for COVID-19 immunization. Medical history included narcolepsy from an unknown date and unknown if ongoing, cataplexy from an unknown date and unknown if ongoing, dermatomyositis from an unknown date and unknown if ongoing, fibromuscular dysplasia from an unknown date and unknown if ongoing, Lupus/SLE from an unknown date and unknown if ongoing, COVID-19 from an unknown date and unknown if ongoing, Known allergies: Penicillin, humira, latex, salmetrol all from an unknown date and unknown if ongoing. Other medications (taken in two weeks) included mycophenolate mofetil hydrochloride (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]); hydroxychloroquine phosphate (PLAQUENIL [HYDROXYCHLOROQUINE PHOSPHATE]); doxycycline; armodafinil (NUVIGIL); oxybate sodium (XYREM), all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0183), dose 1 via an unspecified route of administration, administered in Arm Left on 09Jul2021 at 3:30 (at the age of 42-years-old) as dose 1, single for COVID-19 immunization. Facility type were the patient received vaccine was Doctor's office/urgent care. The patient had COVID prior vaccination, was not COVID tested post vaccination, did not take other vaccine in four weeks. On 05Aug2021 at 10:00 PM (22:00), the patient experienced Extreme muscle pain and weakness throughout entire body. Extreme joint pain throughout entire body, she was barely about to walk up/down steps, sit on toilet, or dress. It was unknown if treatment was taken for events. The patient underwent lab test and procedure which included COVID-19 virus test: Positive on an unspecified date. The outcome of events was not recovered.  Follow-up attempts were completed. No further information was expected.
pt recv vax 2FEB96 & same day post vax pt exp a rash on shoulder which resolved spontaneously & urinary tract irritation;
Both feet felt like they were being twisted off and were very painful, electrical sting. This lasted for twenty minutes, then was only the right foot and had separation between second and third toes. Like a muscle spasm but 10 times worse. Went to ER and was given toradol injection, Motrin, and a steroid dose pack. This subsided by the following morning and then returned on 11/25/21 for 10 minutes. On 11/30/21 started having spasms in left rib cage area and still going on as of 12/01/21. Feet and toes appeared more white when this was occuring, no swelling was noted by Pt.
Information has been received from a registered nurse referring to a female patient of unknown age. On an unknown date, the patient was vaccinated with an unspecified hepatitis B vaccine (manufacturer unknown) (dose and route were unknown) at an unspecified location as an infant. On an unknown date after the vaccination the patient showed negative titers. The patient was revaccinated at an unspecified location sometime in November 2015. At the time of this report, the event outcome and the causality were not reported. Additional information has been requested.
Case number PHEH2013US008343, is an initial spontaneous report received from a nurse on 10 Apr 2013. This report refers to a 17-year-old male patient. His medical history and concomitant medication was not reported. He was vaccinated with MENVEO (conjugated-M102006 and expiry date: Oct 2014), batch number: X12013), at dose of 0.5 ml intramuscularly on 01 Mar 2013. MENVEO vaccine was stored at 33-36 F for 19 days and vaccine was not frozen. No adverse event was reported following this administration error.